Skip to content

PHARMACIE DANIEL: what changed

What changed

PHARMACIE DANIEL

BE 0467.947.004
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€18,216
2024 · -€5,140-€13,076
Equity
-€433,425
2024 · -€415,208-€18,216
Cash
€3,754
2024 · €3,666+€88
Balance sheet total
€281,391
2024 · €287,690-€6,299

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€5,898

    down €5,898 (-2.6%), from €223,138 to €217,239

    of which Land and buildings: -€10,325

  • Stocks and contracts -€3,560

    down €3,560 (-7.8%), from €45,648 to €42,088

  • Receivables within one year +€3,071

    up €3,071 (+20.4%), from €15,063 to €18,134

Equity and liabilities
  • Profit (loss) carried forward -€18,216

    down €18,216 (-3.9%), from -€465,208 to -€483,425

  • Other debts +€14,162

    up €14,162 (+2.3%), from €609,744 to €623,906

  • Advances received -€12,000

    down €12,000 (-85.7%), from €14,000 to €2,000

  • Trade debts +€11,242

    up €11,242 (+39.5%), from €28,467 to €39,709

  • Short-term financial debts -€10,698

    down €10,698 (-28.7%), from €37,313 to €26,615

Income statement
  • Gross operating margin -€11,957

    down €11,957 (-20.3%), from €58,807 to €46,850

  • Depreciation -€3,064

    down €3,064 (-20.3%), from €15,090 to €12,026

  • Staff costs +€2,455

    up €2,455 (+5.9%), from €41,869 to €44,324

  • Financial charges +€1,054

    up €1,054 (+24.1%), from €4,370 to €5,424

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€5,140
Gross operating margin -€11,957
Staff costs -€2,455
Depreciation +€3,064
Other operating charges -€581
Financial income -€93
Financial charges -€1,054
Result 2025 -€18,216
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€7,094
Investment -€6,128
Financing -€878
Cash 2024 €3,666
Net result for the year -€18,216
Depreciation +€12,026
Stocks and contracts +€3,560
Receivables within one year -€3,071
Trade debts +€11,242
Tax, wage and social debts -€609
Advances received -€12,000
Other debts +€14,162
Investment in fixed assets (net) -€6,128
Debts after one year +€6,963
Current portion of long-term debt +€2,857
Short-term financial debts -€10,698
Cash 2025 €3,754
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €287,690 €281,391 -€6,299 -2.2%
Fixed assets 21/28 €223,226 €217,327 -€5,898 -2.6%
Tangible fixed assets 22/27 €223,138 €217,239 -€5,898 -2.6%
Land and buildings 22 €214,945 €204,620 -€10,325 -4.8%
Plant, machinery and equipment 23 €6,595 €5,616 -€979 -14.8%
Furniture and vehicles 24 €1,598 €7,003 +€5,405 +338%
Financial fixed assets 28 €88 €88 = 0.0%
Current assets 29/58 €64,465 €64,064 -€401 -0.6%
Stocks and contracts in progress 3 €45,648 €42,088 -€3,560 -7.8%
Stocks 30/36 €45,648 €42,088 -€3,560 -7.8%
Amounts receivable within one year 40/41 €15,063 €18,134 +€3,071 +20.4%
Trade receivables 40 €15,063 €18,134 +€3,071 +20.4%
Current investments 50/53 €88 €88 = 0.0%
Cash at bank and in hand 54/58 €3,666 €3,754 +€88 +2.4%
Total equity and liabilities 10/49 €287,690 €281,391 -€6,299 -2.2%
Equity 10/15 -€415,208 -€433,425 -€18,216 -4.4%
Contributions 10/11 €50,000 €50,000 = 0.0%
Profit (loss) carried forward 14 -€465,208 -€483,425 -€18,216 -3.9%
Amounts payable 17/49 €702,898 €714,816 +€11,917 +1.7%
Amounts payable after more than one year 17 €0 €6,963 +€6,963
Financial debts 170/4 €0 €6,963 +€6,963
Amounts payable within one year 42/48 €702,898 €707,853 +€4,954 +0.7%
Current portion of amounts payable after more than one year 42 €2,051 €4,908 +€2,857 +139%
Financial debts 43 €37,313 €26,615 -€10,698 -28.7%
Credit institutions 430/8 €37,313 €26,615 -€10,698 -28.7%
Trade debts 44 €28,467 €39,709 +€11,242 +39.5%
Suppliers 440/4 €28,467 €39,709 +€11,242 +39.5%
Advances received on contracts in progress 46 €14,000 €2,000 -€12,000 -85.7%
Taxes, remuneration and social security 45 €11,324 €10,715 -€609 -5.4%
Taxes 450/3 €3,034 €2,938 -€96 -3.2%
Remuneration and social security 454/9 €8,290 €7,777 -€513 -6.2%
Other amounts payable 47/48 €609,744 €623,906 +€14,162 +2.3%
Remuneration, social security and pensions 62 €41,869 €44,324 +€2,455 +5.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €15,090 €12,026 -€3,064 -20.3%
Other operating charges 640/8 €2,711 €3,292 +€581 +21.4%
Gross operating margin 9900 €58,807 €46,850 -€11,957 -20.3%
Operating profit (loss) 9901 -€864 -€12,792 -€11,929 -1,381%
Financial income 75/76B €93 - -€93
Recurring financial income 75 €93 - -€93
Financial charges 65/66B €4,370 €5,424 +€1,054 +24.1%
Recurring financial charges 65 €4,370 €5,424 +€1,054 +24.1%
Profit (loss) for the period before taxes 9903 -€5,140 -€18,216 -€13,076 -254%
Profit (loss) for the period 9904 -€5,140 -€18,216 -€13,076 -254%
Profit (loss) for the period to be appropriated 9905 -€5,140 -€18,216 -€13,076 -254%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.